The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes by Capewell, Paul et al.
The skin is a significant but overlooked anatomical
reservoir for vector-borne African trypanosomes
Paul Capewell, Christelle Cren-Travaille´, Francesco Marchesi, Pamela
Johnston, Taylor-Anne Gorman, Estefania Calvo-Alvarez, Aline Crouzols,
Gre´gory Jouvion, Vincent Jammoneau, William Weir, et al.
To cite this version:
Paul Capewell, Christelle Cren-Travaille´, Francesco Marchesi, Pamela Johnston, Taylor-Anne
Gorman, et al.. The skin is a significant but overlooked anatomical reservoir for vector-




Submitted on 24 Sep 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Distributed under a Creative Commons Attribution 4.0 International License
The skin is a significant but overlooked anatomical reservoir for vector-borne African 1 
trypanosomes 2 
 3 
Paul Capewell1*, Christelle Cren-Travaillé2*, Francesco Marchesi3, Pamela Johnston3, Caroline 4 
Clucas1, Robert A Benson4, Taylor-Anne Gorman1,4, Estefania Calvo-Alvarez2, Aline Crouzols2, 5 
Grégory Jouvion5, Vincent Jammoneau6, William Weir1, M Lynn Stevenson3, Kerry O’Neill1, Anneli 6 
Cooper1, Nono-raymond Kuispond Swar7, Bruno Bucheton6, Dieudonné Mumba Ngoyi8, Paul 7 
Garside4, Brice Rotureau2** and Annette MacLeod1** 8 
 9 
1Wellcome Trust Centre for Molecular Parasitology, College of Medical, Veterinary and Life 10 
Sciences, Henry Wellcome Building for Comparative Medical Sciences, Garscube Estate, Glasgow, 11 
United Kingdom, G61 1QH 12 
2Trypanosome Transmission Group. Trypanosome Cell Biology Unit, INSERM U1201 & Department 13 
of Parasites and Insect Vectors, Institut Pasteur, Paris, France 14 
3Veterinary Diagnostic Services, Veterinary School, University of Glasgow, Garscube Estate, 15 
Glasgow, United Kingdom, G61 1QH 16 
4Institute of Infection, Immunology and Inflammation, College of Medical, Veterinary and Life 17 
Sciences, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom, 18 
G12 8TA 19 
5Human Histopathology and Animal Models Unit, Institut Pasteur, Paris, France 20 
6Institut de Recherche pour le Développement, Unité Mixte de Recherche IRD-CIRAD 177, Campus 21 
International de Baillarguet, Montpellier, France 22 
7University of Kinshasa, Kinshasa, Democratic Republic of the Congo 23 
8Department of Parasitology, National Institute of Biomedical Research (INRB), Kinshasa, 24 
Democratic Republic of the Congo  25 
 26 
* Joint first authors 27 
** Joint last authors 28 
The authors have no competing financial interests.  29 
Keywords 30 
Skin, blood, reservoir, transmission, infection, Human African Trypanosomiasis, trypanosomes, 31 
Trypanosoma brucei, tsetse fly, vector-borne, evolution 32 
  33 
Abstract 34 
The role of mammalian skin in harbouring and transmitting arthropod-borne protozoan parasites has 35 
been overlooked for decades as these pathogens have been regarded primarily as blood-dwelling 36 
organisms. Intriguingly, infections with low or undetected blood parasites are common, particularly 37 
in the case of Human African Trypanosomiasis caused by Trypanosoma brucei gambiense. We 38 
hypothesise, therefore, the skin represents an anatomic reservoir of infection. Here we definitively 39 
show that substantial quantities of trypanosomes exist within the skin following experimental 40 
infection, which can be transmitted to the tsetse vector, even in the absence of detectable 41 
parasitaemia. Importantly, we demonstrate the presence of extravascular parasites in human skin 42 
biopsies from undiagnosed individuals. The identification of this novel reservoir requires a re-43 
evaluation of current diagnostic methods and control policies. More broadly, our results indicate that 44 
transmission is a key evolutionary force driving parasite extravasation that could further result in 45 
tissue invasion-dependent pathology. 46 
  47 
Introduction 48 
Understanding the process of parasite transmission is essential for the design of rational control 49 
measures to break the disease cycle and requires the identification of all reservoirs of infection. In a 50 
number of vector-borne diseases, it is becoming evident that asymptomatic individuals, be they 51 
humans or animals, can represent a significant proportion of the infected population and therefore 52 
an important reservoir of disease that requires targeting by control measures1-4. The recent 53 
identification in West Africa of asymptomatic individuals with human trypanosomiasis (long-term 54 
seropositives) but undetected parasitaemia, raises the question of what role these individuals play 55 
in disease transmission3,5-7. Therapy is currently only directed towards microscopy-positive 56 
individuals and thus a proportion of the infected population remain untreated. 57 
There is convincing evidence that seropositive individuals with low or undetected parasitaemia 58 
contain transmissible trypanosomes. Xenodiagnosis experiments, in which tsetse flies are fed on 59 
microscopy-negative infected humans8 or, more recently, experimentally-infected pigs9, have shown 60 
that these apparently aparasitaemic hosts contain the parasite since the tsetse flies became 61 
infected. It is uncertain where the trypanosomes reside in the host but, given the telmophagus 62 
(slash and suck) feeding habit of the tsetse fly, they could be skin-dwelling parasites ingested with 63 
the blood meal. Our findings suggest that parasites may be sufficiently abundant in the skin to allow 64 
transmission and therefore the skin may represent an anatomical reservoir of infection. 65 
Detection of trypanosomes in the skin is not well documented, although there are descriptions of 66 
cutaneous symptoms associated with African trypanosomiasis and distinct ‘trypanid’ skin lesions10. 67 
Imaging data from mouse models of infection suggest that trypanosomes sequester to major organs 68 
such as the spleen, liver and brain11,12 and recent evidence has demonstrated trypanosomes in 69 
extravascular adipose tissue13. These adipose-associated trypanosomes appear to be a new life-70 
cycle stage with a distinct transcriptional profile and, while tsetse bite-site associated transmission 71 
has been suggested14, and a historical study made a passing observation of localised deposition of 72 
trypanosomes in the skin matrix15, the broader role of skin-dwelling trypanosomes in transmission 73 
remains unclear. In this paper we report the investigation of a possible anatomical reservoir in the 74 
skin of the mammalian host. We provide conclusive evidence of T.b. brucei, (a causative agent of 75 
animal trypanosomiasis) and the human-infective trypanosome, T.b. gambiense, invading the 76 
extravascular tissue of the skin (including but not restricted to the adipose tissue) and undergoing 77 
onward transmission despite undetected vascular parasitaemia. We also provide evidence of 78 
localisation of trypanosomes within the skin of undiagnosed humans. The presence of a significant 79 
transmissible population of T. brucei in this anatomical compartment is likely to impact future control 80 
and elimination strategies for both animal and human trypanosomiases. 81 
  82 
Results 83 
In order to investigate the potential for extravascular skin invasion by T. brucei, BALB/c mice were 84 
inoculated via IP injection with the low virulence STIB247 strain of T. brucei and skin sections were 85 
assessed over a 36-day time-course. The presence and relative quantities of extravascular 86 
parasites were evaluated by semi-quantitative scoring of the histological samples (Figure 1-source 87 
data 1) and compared to blood parasitaemia (Figure 1-source data 2). Extravascular parasites were 88 
first observed in the skin 12 days post-infection and remained throughout the experiment. Skin 89 
parasite numbers fluctuated to a lesser extent than blood parasitaemia and the apparent periodicity 90 
in the skin may be due to one particularly high data point on day 24 (Figure 1). Parasites were found 91 
in the dermis, subcutaneous adipose tissue (Figure 2) and in fascia beneath the panniculus 92 
carnosus muscle. We did not detect any particular clustering around dermal adipocytes. The 93 
presence of parasites in the skin was not associated with major inflammation (Supplementary File 94 
1). To confirm that skin invasion by this parasite was not strain or sub-species specific, the more 95 
virulent TREU927 strain of T. brucei and the human-infective T.b. gambiense strain, PA, were used 96 
to infect mice. Extravascular skin invasion of the dermis, subcutaneous adipose tissue and fascial 97 
planes (Figure 2-figure supplement 1) was evident with associated mild to moderate inflammation 98 
(Supplementary File 2), in some instances the degree of skin invasion in the T.b. gambiense 99 
infected mice was far greater than T.b. brucei, perhaps suggesting a greater propensity for 100 
sequestration in this sub-species.   101 
To confirm that the extravascular distribution of parasites was not an artefact of the route of 102 
inoculation, infections by natural vector transmission were carried out using a bioluminescent T.b. 103 
brucei strain, AnTat1.1E AMLuc/tdTomato. Mice were infected by a single infective bite of an 104 
individual G.m. morsitans. After 4 to 11 days and up to the end of the experiment, parasites were 105 
observed in the skin with a dynamic distribution (Figure 3A) and a variable density (Figure 3B). 106 
Parasites were first detected in the blood between 5 and 19 days after natural transmission and 107 
parasitaemia remained lower than 107 parasites/ml. Observed bioluminescence directly reflects the 108 
total number of living parasites in the entire organism, including blood and viscera, but the intensity 109 
of the signal decreases with tissue depth. Therefore, at the end of each experiment, mice were 110 
sacrificed and their organs were checked for bioluminescence. The presence of extravascular 111 
parasites in cutaneous and subcutaneous tissues was first demonstrated by bioluminescence 112 
imaging in entire dissected skins (Figure 3C) and was not necessarily localised to the bite site. In 113 
addition to the skin, only the spleen, some lymph nodes and adipose tissue were observed to be 114 
positive for bioluminescence in several individuals (Figure 3-figure supplement 1). This suggests 115 
that the observed bioluminescence is likely to originate predominantly, but not solely, from parasites 116 
in the skin. In addition, only mild inflammation was observed after 29 days (Figure 3-figure 117 
supplement 2). 118 
To confirm that trypanosomes in the skin are a viable population, fluorescent parasites were 119 
monitored by two intravital imaging methods following IP injection and natural transmission (Figure 120 
4). First, IP-injected fluorescent T. brucei STIB247 were imaged in vivo using 2-photon microscopy 121 
(Figure 4A). Extravascular trypanosomes observed in the dermal layer of dorsal skin were highly 122 
motile, consistent with viability (Video 1). Second, naturally-transmitted fluorescent T. brucei 123 
AnTat1.1E AMLuc/tdTomato were imaged in vivo using spinning-disk confocal microscopy in the 124 
C57BL/6J-Flk1-EGFP mouse line that has green fluorescent endothelial cells in the lymphatic and 125 
blood vessels16 (Figure 4B). Extravascular trypanosomes were observed in the dermal layer of the 126 
ear and were highly motile (Videos 2, 3 and 4). 127 
Differentiation of dividing trypanosomes to non-dividing stumpy forms is essential for transmission to 128 
the tsetse. Using the relative transcript abundance of the stumpy marker Protein Associated with 129 
Differentiation 1 (PAD1)17 to an endogenous control, Zinc Finger Protein 3 (ZFP3)18, we estimated 130 
that approximately 20% of skin-dwelling parasites were stumpy (Supplementary File 3). To directly 131 
determine the proportion of stumpy forms in skin sections, histological staining for PAD1 was also 132 
performed (Table 1-source data 4). PAD1-positive cells were observed in variable proportions (from 133 
8 to 80%) in all bioluminescent skin samples examined after IP injection (Supplementary File 4). 134 
Following natural transmission, up to 38% of parasites detected using VSG surface markers (Figure 135 
3-figure supplement 3A-B) also expressed PAD1 (Figure 3-figure supplement 3C-D) (n=441 cells 136 
from 8 skin sections). In all skin sections, stumpy parasites were homogenously distributed in the 137 
dermis and subcutaneous adipose tissues. 138 
We next assessed the ability of skin-dwelling parasites to infect tsetse flies. Teneral flies (immature 139 
flies that have not yet taken a blood meal) were fed on different regions of skin from mice infected 140 
with AnTat1.1E AMLuc/TY1/tdTomato with differing levels of bioluminescence across the skin 141 
(Table 1-source data 1 and Table 1-source data 2). This was repeated in 20 mice with differing 142 
levels of parasitaemia. Flies were dissected and checked for the presence of fluorescent 143 
trypanosomes after two days (Table 1). In mice with undetectable or low parasitaemia (<5x104 144 
parasites/ml), no parasites were found in flies fed on non-bioluminescent regions. Conversely, a 145 
median of 36% (±23%, n=70) of flies that fed on bioluminescent regions of low parasitaemic mice 146 
became infected (Table 1 and Table 1-source data 3). This demonstrates that skin parasites, from 147 
mice without visible parasitaemia, can contribute to tsetse infection, possibly reflecting human 148 
asymptomatic infections. When parasites were detected in the blood and skin, tsetse infection rates 149 
increased up to 100% (median of 61% ±22%, n=120) (Table 1  and Table 1-source data 3). 150 
Parasites taken-up from the skin were able to further develop through the life-cycle to early procyclic 151 
forms in the fly as evidenced by GPEET-procyclin marker on the parasites surface (n=721 cells from 152 
16 flies) (Table 1-source data 4 and Supplementary File 4). 153 
To demonstrate that skin invasion by trypanosomes can occur in humans as well as the murine 154 
model, slides of historical skin biopsies, taken as part of a diagnostic screening programme for 155 
Onchocerca microfilaria in the trypanosomiasis-endemic Democratic Republic of the Congo, were 156 
examined for trypanosomes. At the time of sampling, the incidence of trypanosomiasis was 1.5-2% 157 
and we hypothesised that some individuals may have harboured undiagnosed infections. Re-158 
examination of 1,121 skin biopsies by microscopy revealed six individuals with trypanosomes in 159 
their skin (Figure 5). These individuals had not previously been diagnosed with human 160 
trypanosomiasis by clinical signs or the presence of blood parasites. 161 
 162 
Discussion 163 
We have shown that there exists a significant yet overlooked population of live, motile, 164 
extravascular T. brucei in the dermis and subcutis of animal models infected by artificial routes or by 165 
vector transmission. It is likely that once injected the parasites disseminate via the lymph and blood 166 
to the skin where they are ingested during tsetse fly pool-feeding and readily initiate cyclical 167 
development in the vector. Given the relative volume of the skin organ compared to the vasculature, 168 
it is possible, depending on the density of skin invasion, that more parasites exist in the skin than in 169 
the blood. The skin, therefore, represents an unappreciated reservoir of infection. The extravasation 170 
of trypanosomes was described previously in major organs such as liver, spleen11,12 and visceral 171 
adipose tissue13, but the importance of these parasites in transmission was not investigated. Here 172 
we show that these skin-dwelling trypanosomes contribute to transmission and could explain the 173 
maintenance of disease foci, despite active screening and treatment. Skin invasion for enhanced 174 
transmission is likely a powerful evolutionary force driving extravasation, suggesting that the 175 
generalised tissue penetration underlying pathogenesis (i.e. splenomegaly, hepatomegaly, CNS 176 
invasion) is a secondary epiphenomenon. A skin reservoir also presents a novel target for 177 
diagnostics (e.g. skin biopsies), allowing the prevalence of infection to be accurately determined 178 
and the identification of any previously undetected animal reservoirs of human disease. 179 
The skin as an anatomical reservoir of parasites is a recurring theme in arthropod-borne human 180 
diseases such as Leishmania19,20 and Onchocerca21,22. Here we present evidence of trypanosomes 181 
in the skin of hitherto undiagnosed individuals. This anatomical reservoir may serve to explain how 182 
HAT foci re-emerge and persist despite low numbers of reported cases even in the absence of an 183 
animal reservoir23-25. 184 
HAT was once widespread across much of sub-Saharan Africa but concerted control efforts brought 185 
it close to elimination during the 1960s26,27. However, disease foci persisted, with a resurgence in 186 
the number of reported cases to over 300,000 in the 1990s26-28. Currently, HAT is approaching 187 
elimination in many areas27,29. Understanding how HAT evaded elimination in the latter half of the 188 
20th century and how it continues to persist is vital to efforts to eliminate the disease. For example, 189 
our results indicate that it may be necessary to develop novel therapeutics capable of accessing 190 
extravascular compartments. The current policy in most endemic countries is not to treat 191 
serologically positive individuals unless they demonstrate active infection, due to the long duration 192 
and high toxicity of treatment and the low predictive value of the serological tests. We suggest that 193 
this policy should be reconsidered in light of our compelling evidence that they represent a carrier 194 
population which may maintain HAT foci and explain previously thwarted efforts to eliminate this 195 
major pathogen. 196 
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Trypanosome strains and cultures 310 
All strains used in this study are pleomorphic. STIB247 is a low virulence T.b. brucei strain that 311 
induces a chronic infection and was isolated from a hartebeest in the Serengeti in 197130. TREU927 312 
is the genome reference strain for T. brucei and is more virulent than STIB247. This strain was 313 
isolated from a tsetse fly in Kenya in 1969/197031. PA is a human-infective group 1 T.b. gambiense 314 
strain isolated from a patient in the Democratic Republic of the Congo in 197532. mCherry STIB247 315 
was created by transfection of STIB247 with pHD1034-mCherry33. This strain constitutively 316 
expresses fluorescent mCherry from the ribosomal RNA promoter and its expression is stable over 317 
repeated passage. 318 
The AnTat 1.1E clone of T.b. brucei was derived from a strain originally isolated from a bushbuck in 319 
Uganda in 196634. Bloodstream forms were cultivated in HMI11 medium supplemented with 10% 320 
foetal calf serum at 37°C in 5% CO2. This strain was genetically engineered to produce two strains 321 
continuously expressing the red-shifted luciferase (PpyRE9H) and the tdTomato red fluorescent 322 
protein either individually or in combination. 323 
For the first AnTat 1.1E strain, the pTbAMLuc plasmid (M. Taylor, London School of Hygiene and 324 
Tropical Medicine, UK) was used for continuous cytosolic expression of the red-shifted luciferase 325 
PpyRE9H. The tdTomato coding sequence was cloned with HindIII and BamHI into the pTSARib 326 
vector35, generating the final pTSARib-tdTomato construct. The two plasmids were linearised with 327 
KpnI and SphI restriction enzymes, respectively, and used to transform procyclic parasites with an 328 
Amaxa Nucleofector (Lonza)36. After 24h, transfected cells were selected by the addition of 329 
blasticidin or puromycin (10μg/ml). After one week, the population was examined (i) for red 330 
fluorescence by fluorescence microscopy and (ii) for both red fluorescence and bioluminescence by 331 
using a fluorimeter Infinite® 200 (Tecan). Cells were sub-cloned by limiting dilution, and clone 332 
selection was performed after 15 days by measuring both bioluminescence in a microplate reader 333 
Infinite® 200 (Tecan) and fluorescence with a Muse® cell Analyzer (Merck-Millipore). This strain, 334 
named AnTat1.1E AMLuc/tdTomato, was used for natural transmission experiments. 335 
The second AnTat 1.1E strain expressing the 3.1 Kb chimeric multiplex reporter protein 336 
PpyRE9H::TY1::tdTomato was named AnTat 1.1E AMLuc/TY1/tdTomato. This cytoplasmic reporter 337 
is composed of three distinct markers: the red-shifted luciferase (PpyRE9H) is fused to the 338 
tdTomato red fluorescent protein by a TY1 tag. Briefly, the 1.68 Kb optimised version of the North 339 
American firefly Photinus pyralis luciferase37 was fused with a 10-bp sequence known as TY1-tag38 340 
and cloned into the pTSARib plasmid35 by using XhoI and HindIII restriction enzymes to obtain the 341 
pTSARib-PpyRE9H-TY1 plasmid. Finally, the 1.4 Kb coding region of the tdTomato fluorescent 342 
protein was inserted downstream using HindIII and BamHI. The resulting 8.9 Kb vector, containing a 343 
blasticidin S resistance cassette, was linearised with SphI to integrate the rDNA promoter locus. 344 
Bloodstream parasites were transformed with an Amaxa Nucleofector (Lonza)36, sub-cloned by 345 
limiting dilution, and clone selection was performed by measuring both bioluminescence in a 346 
microplate reader Infinite® 200 (Tecan) and fluorescence with a Muse® cell Analyzer (Merck-347 
Millipore). The selected AnTat 1.1E AMLuc/TY1/tdTomato sub-clone was comparable to the 348 
parental wild-type strain in terms of growth rate (Table 1-source data 1A), pleomorphism (Table 1-349 
source data 4C), tsetse infectivity and virulence in mice (Table 1-source data 2). In order to verify 350 
the reliability of the bioluminescent marker as well as to define the bioluminescence detection 351 
threshold of the AnTat 1.1E AMLuc/TY1/tdTomato selected sub-clone, a parasite density / 352 
bioluminescence intensity analysis was performed in 96-micro-well plates with an IVIS® Spectrum 353 
imager (Perkin Elmer). Parasite density and bioluminescence intensity were correlated when 354 
bioluminescence levels were higher than 104 p/s/cm²/sr, corresponding to about 103 parasites, 355 
allowing estimation of the parasite density from in vivo imaging over this threshold (Table 1-source 356 
data 1B). This correlation was verified by quantification in a microplate reader Infinite® 200 (Tecan) 357 
at the very beginning of the first in vivo experiment as well as the end of the last one, demonstrating 358 
the stability of the triple reporter expression in the AnTat 1.1E AMLuc/TY1/tdTomato selected sub-359 
clone over time, especially after at least one full in vivo parasite cycle in the tsetse fly and the 360 
mammalian host (Table 1-source data 1C). This strain was used for xenodiagnosis experiments and 361 
quantification of parasite densities.  362 
 363 
Mouse strains 364 
BALB/c and C57BL/6J mice were used as models for chronic disease39. In addition, to allow for 365 
further 3D intravital imaging of the lymphatic and blood systems, C57BL/6J-Flk1-EGFP mice 366 
expressing a GFP tagged Kdr (Flk1) gene encoding the vascular endothelial growth factor receptor 367 
2 (VEGFR-2) were used16. 368 
Ethical statements 369 
This study was conducted under Home Office and SAPO regulations in the UK and in strict 370 
accordance with the recommendations from the Guide for the Care and Use of Laboratory Animals 371 
of the European Union (European Directive 2010/63/UE) and the French Government. The protocol 372 
was approved by the “Comité d’éthique en expérimentation animale de l’Institut Pasteur” CETEA 89 373 
(Permit number: 2012-0043 and 2016-0017) and undertaken in compliance with Institut Pasteur 374 
Biosafety Committee (protocol CHSCT 12.131). 375 
 376 
Skin invasion time-course 377 
A total of 36 eight-week old BALB/c mice (Harlan, UK) were inoculated by intra-peritoneal (IP) 378 
injection with 104 parasites of strain STIB 247. Parasitaemia was assayed on each subsequent day 379 
using phase microscopy40. Twenty-four uninfected animals served as controls. Every three days for 380 
36 days, three infected animals and two uninfected animals were culled and 2cm2 skin samples 381 
removed from the dorsum. Skin samples were fixed in 10% neutral buffered formalin prior to 382 
histological analysis. 383 
 384 
Natural infections using tsetse flies 385 
Tsetse flies (Glossina morsitans morsitans) were maintained, infected and dissected at the Institut 386 
Pasteur as described previously41. Flies were infected with AnTat1.1E AMLuc/tdTomato parasites. 387 
Positive flies were selected first by screening the abdominal fluorescence (midgut infection) 15 days 388 
after the infective meal, and then by a salivation test (mature salivary gland infection) after one 389 
month. Single flies with salivary gland infections were used to infect the abdomen of mice 390 
anaesthetised by IP injection of ketamine (Imalgene 1000 at 125mg/kg) and xylazine (Rompun 2% 391 
at 12.5mg/kg) and feeding was confirmed by visual observation of the fly abdomen full of blood. 392 
Control mice were either not bitten or bitten by uninfected flies. The presence and density of 393 
parasites in the blood was determined daily by automated fluorescent cell counting with a Muse 394 
cytometer (Merck-Milllipore, detection limit 5.102 parasites/ml) or by direct examination under a 395 
phase microscope with standardised one-use haemocytometers (Hycor Kova, detection limit 104 396 
parasites/ml), according to the manufacturer’s recommendations. 397 
 398 
Infection for xenodiagnosis 399 
A total of 20 seven-week-old male C57BL/6J Rj mice (Janvier, France) were IP injected with 105 400 
AnTat 1.1E AMLuc/TY1/tdTomato bloodstream forms. Parasitaemia was assayed daily by 401 
automated fluorescent cell counting with a Muse cytometer (Merck-Millipore, detection limit 5.102 402 
parasites/ml) according to the manufacturer’s recommendations. 403 
PAD1/ZFP3 relative expression 404 
Three BALB/c were infected with T.b. brucei strain TREU927 and culled at day 11. The mice were 405 
perfused and a 2cm2 region of skin removed from the flank. Skin sections were lysed using a 406 
Qiagen Tissuelyzer LT and RNA extracted using a Qiagen RNAeasy kit following the manufacturer’s 407 
instructions. 100ng of RNA from each sample was reverse-transcribed using an Invitrogen 408 
Superscript III RT kit. qPCR was performed on each sample using 5µl of cDNA using a protocol and 409 
primers validated previously42 on an Agilent Technologies Stratagene Mx3005P qPCR machine. 410 
The ratio of PAD1 to ZFP3, and hence the proportion of cells transcribing the PAD1 gene, was 411 
estimated using the Agilent Technologies MXPro software. 412 
Xenodiagnosis 413 
Mice were first anaesthetised by IP injection of ketamine (Imalgene 1000 at 125 mg / kg) and 414 
xylazine (Rompun 2% at 12.5 mg/kg). Batches of 10 teneral male tsetse flies (from 8 to 24 h post-415 
eclosion) were then placed in 50 ml Falcon tubes closed with a piece of net through which they 416 
were allowed to feed directly on mouse skin regions of interest for 10 minutes. The selection of the 417 
skin regions for fly feeding was based on mice bioluminescence profiles and parasitaemia. Unfed 418 
flies were discarded and fed flies were maintained as previously described. Anaesthetised mice 419 
were finally sacrificed by cervical dislocation and their skin was dissected for controlling 420 
bioluminescence with an IVIS® Spectrum imager (Perkin Elmer). All the flies were dissected and 421 
checked for the presence of trypanosomes either 2 or 14 days after their meal on mouse skin by 422 
two entomologists blinded to group assignment and experimental procedures. Dissections were 423 
performed as previously described41, entire midguts were scrutinised by fluorescence microscopy to 424 
detect and count living red fluorescent parasites, and positive midguts were further treated for IFA. 425 
A total of 420 flies were used in 3 independent xenodiagnosis experiments. 426 
 427 
In vitro bioluminescence imaging 428 
To perform the parasite density / bioluminescence intensity assay with AnTat 1.1E 429 
AMLuc/TY1/tdTomato bloodstream forms, parasites were counted, centrifuged and resuspended in 430 
fresh HMI11 medium at 10.106 cells/ml. Then, 100μl (or 106 parasites) of this suspension were 431 
transferred into black clear-bottom 96-well plates and serial 2-fold dilutions were performed in 432 
triplicate adjusting the final volume to 200μl of HMI11 with 300 μg/ml of beetle luciferin (Promega, 433 
France). Luciferase activity was quantified after 10 minutes of incubation with a microplate reader 434 
Infinite® 200 (Tecan), following the instructions of the Promega Luciferase Assay System. After 435 
background removal, results were analysed as mean ±SD of three independent experiments. 436 
In vivo bioluminescence imaging 437 
Infection with bioluminescent parasites was monitored daily by detecting the bioluminescence in 438 
whole animals with the IVIS® Spectrum imager (Perkin Elmer). The equipment consists of a cooled 439 
charge-coupled camera mounted on a light-tight chamber with a nose cone delivery device to keep 440 
the mice anaesthetised during image acquisition with 1.5% isofluorane. D-luciferin potassium salt 441 
(Promega) stock solution was prepared in phosphate buffered saline (PBS) at 33.33 mg/ml, filter-442 
sterilised and stored in a -20°C freezer. To produce bioluminescence, mice were inoculated IP with 443 
150 μl of D-luciferin stock solution (250mg/kg). After 10 minutes of incubation to allow substrate 444 
dissemination, all mice were anaesthetised in an oxygen-rich induction chamber with 2% 445 
isofluorane, and images were acquired by using automatic exposure (30 seconds to 5 minutes) 446 
depending on signal intensity. Images were analysed with Living Image software version 4.3.1 447 
(Perkin Elmer). Data were expressed in average radiance (p/s/cm²/sr) corresponding to the total flux 448 
of bioluminescent signal according to the selected area (total body of the mouse here). The 449 
background noise was removed by subtracting the bioluminescent signal of the control mouse from 450 
the infected ones for each acquisition. 451 
2-photon microscopy 452 
Intravital multi-photon microscopy studies were carried out using a Zeiss LSM7 MP system 453 
equipped with a tuneable titanium:sapphire solid-state two-photon excitation source (4W, 454 
Chameleon Ultra II, Coherent Laser Group) coupled to an Optical Parametric Oscillator (Chameleon 455 
Compact OPO; Coherent). Movies were acquired for 10 to 15 minutes with an X:Y pixel resolution 456 
of 512 x 512 in 2μm Z increments producing up to 40μm stacks. 3D tracking was performed using 457 
Volocity 6.1.1 (Perkin Elmer, Cambridge, UK). Values representing the mean velocity, displacement 458 
and meandering index were calculated for each object. Mice were anaesthetised IP using 459 
medetomidine (Domitor 0.5mg/kg) and ketamine (50mg/kg) and placed on a heated stage. 460 
Following removal of hair with a depilatory cream, dorsal skin was imaged. An intravenous injection 461 
of non-targeted quantum dots (Qdot705) (Life Technologies, UK) prior to imaging allowed 462 
visualisation of blood vessels. 463 
Spinning-disk confocal microscopy 464 
AnTat1.1E AMLuc/tdTomato parasites were monitored in the ear of Kdr (Flk1) C57BL/6J Rj mice by 465 
spinning-disk confocal microscopy as described previously41. Briefly, mice were first anaesthetised 466 
by IP injection of ketamine (Imalgene 1000 at 125mg/kg) and xylazine (Rompun 2% at 12.5mg/kg). 467 
Mice were wrapped in a heating blanket and placed on an aluminium platform with a central round 468 
opening of 21mm in diameter. A coverslip was taped on the central hole and the mouse was 469 
positioned so that the ear was lying on this oiled coverslip. Imaging was performed using an 470 
UltraView ERS spinning-disk confocal system (Perkin Elmer) with a x40 oil objective (1.3 numerical 471 
aperture). Movies were acquired by an EM-CCD camera (Hamamatsu) controlled by the Volocity 472 
software (Perkin Elmer) with an exposure time of 500ms for a total of 30 to 120s. Images were 473 
analysed using ImageJ 1.48v and its plugin Bio-formats importer (NIH). 474 
Histological and immunohistochemical evaluation of the skin 475 
Paraformaldehyde-fixed skin samples were trimmed and processed into paraffin blocks. Sections 476 
were stained with Haematoxylin and Eosin (HE). Additional serial sections were processed for 477 
immunohistochemical staining using a polyclonal rabbit antibody raised against the invariant surface 478 
glycoprotein 65 (IGS65) (M. Carrington, Cambridge, UK) using a Dako Autostainer Link 48 (Dako, 479 
Denmark) and were subsequently counterstained with Gill’s Haematoxylin.  480 
Histopathological assessment of inflammation in the skin 481 
The extent of cutaneous inflammatory cell infiltration was assessed in haematoxylin and eosin 482 
stained sections with a semi-quantitative scoring system applied by two pathologists blinded to 483 
group assignment and experimental procedures. The extent of mixed inflammatory cell infiltration in 484 
the dermis and/or subcutis was assessed on a 0 to 3 grading scale (0 = no inflammation or only few 485 
scattered leukocytes; 1 = low numbers of inflammatory cells; 2 = moderate numbers of inflammatory 486 
cells; 3 = large numbers of inflammatory cells). Ten high-power fields were scored for each skin 487 
sample. An inflammation score calculated as the average of the scores in the 10 high-power fields 488 
was determined for each sample. 489 
Semi-quantitative evaluation of the parasite burden in skin sections 490 
Parasite burden was assessed in skin sections stained with anti-IGS65 antibody by two pathologists 491 
blinded to group assignment and experimental procedures. Presence of parasites defined as 492 
intravascular (parasites within the lumen of dermal or subcutaneous small to medium-sized vessels) 493 
and extravascular (parasites located outside blood vessels, scattered in the connective tissue of the 494 
dermis or in the subcutis) was evaluated in 5 randomly selected high-power fields at x40 495 
magnification with a 0 to 3 semi-quantitative grading scale (0 = no parasites detectable; 1 = low 496 
numbers of parasites (< 20); 2 = moderate numbers of parasites (20 < 50); 3 = large numbers of 497 
parasites (> 50). An average parasite burden score was calculated for each sample. 498 
Immunofluorescence analysis 499 
Cells were treated for immunofluorescence after paraformaldehyde or methanol fixation as 500 
described previously17. Parasites were stained with one or two of the following antibodies: (i) the 501 
anti-CRD polyclonal rabbit antibody (1:300) to label the cross-reactive determinant of the 502 
glycosylphosphatidylinositol anchors of proteins, predominantly the variant surface glycoproteins43, 503 
(ii) the anti-PAD1 polyclonal rabbit antibody (1:100) targeting the carboxylate-transporter Proteins 504 
Associated with Differentiation 1 (PAD1) (Keith Matthews, Edinburgh, UK)17, (iii) the anti-GPEET 505 
mouse IgG3 monoclonal antibody (1:500) targeting the T. brucei GPEET-rich procyclin (Acris 506 
Antibodies GmbH, San Diego, USA), (iv) the L8C4 mouse IgG1 monoclonal antibody labelling an 507 
epitope of the PFR2 protein44. Specific antibodies with minimal cross-reactions with mice and 508 
coupled to AlexaFluor 488, Cy3 or Cy5 (Jackson ImmunoResearch, USA) were used as secondary 509 
antibodies. DNA was stained with 4,6-diamidino-2-phenylindole (DAPI). IFA image acquisition was 510 
carried out on a Leica 4000B microscope with a x100 objective lens using a Hamamatsu ORCA-511 
03G camera controlled by Micro-manager and images were normalised and analysed with ImageJ 512 
1.49v (NIH). 513 
Histopathology of Historical Human Skin Samples  514 
Historical human skin samples were collected from 1991 to 1995 as part of The National 515 
Onchocerciasis Task Force (NOTF)45. Of this collection, 1,121 paraffin embedded skin samples 516 
were cut into 2.5 micron sections and stained with Giemsa (Sigma-Aldrich). Slides were screened 517 
for the presence of parasites by two pathologists independently and representative images taken at 518 
x100 magnification.   519 
 520 
Figure 1. Parasite densities in the blood and in the extravascular tissue of the skin over a 521 
time-course 522 
The blood parasitaemia of T.b. brucei strain STIB247 (red) and the semi-quantitative score of 523 
extravascular parasites in the skin (blue) are shown over a 36-day time-course following infection in 524 
Balb/C mice. Blood parasitaemia was measured using phase microscopy using methodology 525 
outlined in 40. Skin parasite burden is an average of five high-power fields scored by histological 526 
analysis (0 = no parasites detectable; 1 = low numbers of parasites; 2 = moderate numbers of 527 
parasites; 3 = large numbers of parasites). Standard error shown (n=3). 528 
  529 
 530 
Figure 2. Extravascular localisation of trypanosomes during an infection 531 
Histological sections of dorsal skin from uninfected and infected Balb/C mice stained with 532 
trypanosome-specific anti-ISG65 antibody (brown), counterstained with Gill’s Haematoxylin stain 533 
(blue) at 12 days and 24 days post-inoculation with T.b. brucei strain STIB247. Parasites are visible 534 
in extravascular locations of the skin including the deep dermis and subcutaneous adipose tissue 535 
from day 12. The scale bar represents 20µm. 536 
  537 
 538 
Figure 3. Dynamics of parasite distribution in the extravascular tissue of the skin and in the 539 
blood during a representative course of infection following natural transmission 540 
A total of seven mice were infected by the single infective bite of an individual G.m. morsitans on 541 
the belly with the T.b. brucei AnTat1.1E AMLuc/tdTomato strain. Panels A and C depict 542 
representative patterns. (A) Examples of bioluminescence profiles of 3 mice (+ bitten by an infected 543 
fly, - bitten by an uninfected fly and 0 not bitten) 6, 12, 20 and 26 days after the bite are shown. (B) 544 
Ventral (blue) and dorsal (green) bioluminescence (BL) intensities (in p/s/cm2/sr on the left Y-axis) 545 
and parasitaemia (in parasites/ml in red on the right Y-axis) were measured daily for 29 days and 546 
plotted as mean ±SD (n=7 mice). (C) The entire skins of mice (+) and (-) were dissected for 547 
bioluminescence imaging 29 days after the bite. For the mouse (+), Figure 3–figure supplement 1 548 
shows the bioluminescence profile of dissected organs, Figure 3–figure supplement 2 presents the 549 
skin inflammation, and Figure 3–figure supplement 3 shows labelled parasites in skin sections.  550 
 551 
Figure 4. Extravascular localisation of trypanosomes during an infection visualised using 552 
multi-photon microscopy (A) and spinning-disk confocal microscopy (B) 553 
(A) Still-image extracted from video (Video 1) of multi-photon live imaging of dorsal skin during a 554 
trypanosome infection. Intravenous non-targeted quantum dots (white) highlight blood vessels. T.b. 555 
brucei STIB 247 parasites transfected with mCherry to aid visualisation (red) are clearly visible and 556 
motile outside the vasculature and within the extravascular skin matrix (green). (B) Still-image 557 
extracted from (Video 3) of spinning-disk confocal live imaging of the ear of an Kdr (Flk1) C57BL/6J 558 
Rj mouse during a trypanosome infection. T.b. brucei AnTat1.1E AMLuc/tdTomato parasites 559 
expressing tdTomato (red) are moving in the extravascular region surrounding a vessel of the 560 
dermis (green). 561 
  562 
 563 
 564 
Figure 5. Extravascular localisation of trypanosomes in previously unidentified human cases 565 
of trypanosomiasis 566 
Histological sections of skin collected from previously unidentified cases of human trypanosomiasis 567 
from the Democratic Republic of Congo, showing the presence of extravascular parasites in 568 
biopsies from three individuals (A, B and C). Skin biopsies were collected as part of a national 569 
onchocerciasis screening programme that took place in the same geographic region as an active 570 
trypanosomiasis focus. Slides were stained with Giemsa and examined under oil immersion at 100x 571 
magnification. In addition to visible slender forms (black arrows) in the extravascular tissue of the 572 
skin, a clearly identifiable stumpy transmission form with typical morphology and an unattached 573 
undulating membrane is also present in the skin of one individual (red arrow in A). The scale bar 574 
represents 5µm. 575 
  576 
Fly batches Parasites in blood 
(per ml) 
Parasites in skin 
(per cm2) 
Dissected flies Fly infection rates 
(%) 
C1 0 0 32 0% 
C 0 0 8 0%
A4B < 104 < 103 16 0% 
B1B 2.2x104 < 103 13 0% 
A4A < 104 6.6x105 17 35%
A2A 1.1x104 3.8x106 7 86% 
B1A 2.2x104 4.6x107 16 31% 
3B 4.4x104 2.6x104 14 36% 
3A 4.4x104 2.6x104 16 38% 
1B 1.8x105 8.0x103 12 67% 
1A 1.8x105 8.0x103 14 79% 
4B 2.2x105 1.2x104 17 53%
4A 2.2x105 1.2x104 18 56%
2B 1.6x106 8.0x103 14 36%
2A 1.6x106 3.2x104 18 39%
B4B 4.3x106 6.7x107 10 80%
B4A 4.3x106 6.7x107 17 100%
 577 
Table 1. Skin parasites are ingested during tsetse pool-feeding 578 
Mice were IP infected with T.b. brucei AnTat1.1E AMLuc/TY1/tdTomato and the parasitaemia and 579 
bioluminescence were monitored daily until the day of xenodiagnosis. The number of parasites in 580 
the blood was determined using a haemocytometer or a flux cytometer. The number of parasites in 581 
the skin was estimated from the measured bioluminescence intensity by using a standard curve 582 
(Table 1-source data 1 and Table 1-source data 2). Batches of teneral flies were fed on different 583 
skin regions of mice infected with differing levels of bioluminescence across the skin and with 584 
differing levels of parasitaemia (Table 1-source data 2 and Table 1-source data 3). Fly batches A4A, 585 
A2A, B1A, 3B and 3A were used to assess tsetse transmission in hosts with low numbers of blood 586 
parasites but high numbers skin parasites, while fly batches 1B, 1A, 4B, 4A, 2B, 2A, B2B and B4A 587 
were used to investigate the impact of high numbers of parasites in both the skin and blood. Flies 588 
were dissected and their midguts checked for the presence of fluorescent trypanosomes after two 589 
days to determine the proportion of infected flies (Table 1-source data 4A-B). For some of these 590 
experiments, results of an in-depth quantification of parasite stages by IFA is provided in 591 
Supplementary file 4. Stumpy forms were observed only in the blood of mice with parasitaemia 592 
values highlighted in light grey. Bioluminescence was detected in the skin of mice with values 593 
highlighted in dark grey. 594 
Figure Supplements 595 
 596 
Figure 2-figure supplement 1. Skin invasion by T.b. brucei strain TREU927 and T.b. 597 
gambiense strain PA 598 
Histological sections of dorsal skin from a mouse infected with T.b. brucei strain TREU927 at 20x 599 
magnification and two mice infected with T.b. gambiense strain PA at 40x magnification 10-days 600 
post-inoculation. Trypanosome-specific anti-ISG65 antibody reveals the presence of extravascular 601 
parasites (brown) and the slides were counterstained with Gill’s Haematoxylin stain (blue) to reveal 602 
host skin structure. 603 
 604 
Figure 3-figure supplement 1. Bioluminescence mostly originates from parasites in the skin 605 
Mouse (+) was sacrificed and dissected for bioluminescence imaging 29 days after the infective 606 
bite. Fig 3C shows the bioluminescence profile of its entire skin and dissected organs are shown 607 
here.  608 
 609 
Figure 3-figure supplement 2. Mild inflammation of skin tissues one month after an infection 610 
by natural transmission 611 
After 29 days, the most bioluminescent skin region of mouse (+) was dissected, fixed in 612 
paraformaldehyde, embedded in paraffin and stained with HE. Multifocal inflammatory infiltrates 613 
containing neutrophils were located in the dermis and subcutaneous tissue and associated with 614 
oedema. Inflammatory foci were generally centred on blood vessels (arrows). 615 
 616 
Figure 3-figure supplement 3. Extravascular parasites in the skin express both VSGs and 617 
PAD1 surface markers 618 
After 29 days, the most bioluminescent skin region of mouse (+) was dissected, fixed in 619 
paraformaldehyde, embedded in paraffin and treated for IFA with the anti-CRD antibody that 620 
predominately labels parasites expressing VSGs (A-B), or the anti-PAD1 antibody specific to 621 
transmission form “stumpy” cells (C-D).  622 
Source Data 623 
 624 
Table 1-source data 1. Characterisation of the AnTat 1.1E AMLuc/TY1/tdTomato sub-clone 625 
(A) The in vitro growth of the selected AnTat1.1E AMLuc/TY1/tdTomato sub-clone (red) was similar 626 
to that of the parental wild-type strain (blue). Bloodstream forms were cultured in HMI11, counted 627 
daily in a Muse cytometer (Merck-Millipore) and diluted after 4 days. (B) A parasite density / 628 
bioluminescence intensity analysis was performed by measuring the bioluminescence in successive 629 
2-fold dilutions in 96-micro-well plates with an IVIS® Spectrum imager (Perkin Elmer). When plotted 630 
as mean ±SD (n=3), parasite densities and bioluminescence intensities were correlated when the 631 
bioluminescence levels were higher than 104 p/s/cm²/sr, corresponding to about 103 parasites, 632 
allowing estimation of the parasite density from in vivo imaging over this threshold. This standard 633 
curve was used to estimate the number of parasites in the skin from measured values of 634 
bioluminescence. (C) This correlation was verified by quantification in a microplate reader Infinite® 635 
200 (Tecan) at the very beginning of the first in vivo experiment as well as the end of the last one 636 
(mean ±SD, n=3).  637 
 638 
Table 1-source data 2. Parasite densities in extravascular tissue of the skin and in the blood 639 
of mice used for differential xenodiagnosis 640 
Mice were injected IP with AnTat1.1E AMLuc/TY1/tdTomato and monitored daily for 641 
bioluminescence and parasitaemia. (A) Bioluminescence profile of four mice (- uninfected control 642 
and (1-3) three infected mice) four days after infection. (B) The entire skins of the uninfected control 643 
mouse (-) and mouse 3 were dissected for bioluminescence imaging four days after infection. (C) 644 
Parasite densities in the blood and in the skin (calculated from the mean dorsal bioluminescence 645 
intensity measurement and from the standard curve in Figure 4-figure supplement 3B, in 646 
parasites/cm2 in blue) were calculated daily over one week and plotted as mean ± SD (n=13 mice). 647 
Table 1-source data 3. Skin parasites are sufficient to initiate a tsetse infection 648 
Schematics summarising the principal results from the xenodiagnosis experiment. In a mouse with 649 
no detected transmissible parasites in the blood (absence of stumpy forms by IFA and absence of 650 
infection of flies fed on a non-bioluminescent region of the skin), flies can ingest transmissible 651 
parasites from the bioluminescent region of the skin (left panel). When a mouse presents 652 
transmissible forms in the blood, fly infection rates increase with the concomitant ingestion of 653 
parasites from the skin (right panel). Values correspond to those obtained for mouse A4 and B4. 654 
 655 
Table 1-source data 4. Parasite stage determination by labelling of specific surface markers 656 
Parasites recovered from infected tsetse midguts (A-B) or included in bloodsmears (C) were fixed in 657 
methanol for 5 seconds and stained either with the anti-GPEET antibody detecting early procyclic 658 
forms (red in A-B) and the L8C4 antibody labelling the flagellum PFR (green in A-B), or with the 659 
anti-PAD1 antibody detecting intermediate and stumpy forms (green in C), respectively. 660 
 661 
Figure 1-source data 1. Semi-quantitative evaluation of the parasite burden in skin sections 662 
(STIB247) 663 
Every three days for 36 days of a STIB247 T.b. brucei infection, five mice were culled (three 664 
infected, two control) and skin sections stained with parasite-specific anti-IGS65 antibody. Parasite 665 
burden was assessed by two pathologists blinded to group assignment and experimental 666 
procedures. Presence of parasites defined as intravascular (parasites within the lumen of dermal or 667 
subcutaneous small to medium-sized vessels) and extravascular (parasites located outside blood 668 
vessels, scattered in the connective tissue of the dermis or in the subcutis) was evaluated in 5 high-669 
power fields at x40 magnification with a 0 to 3 semi-quantitative grading scale (0 = no parasites 670 
detectable; 1 = low numbers of parasites; 2 = moderate numbers of parasites; 3 = large numbers of 671 
parasites).  672 
 673 
Figure 1-source data 2. Daily parasitaemia during STIB247 infection in Balb/C mice 674 
The daily parasitaemia during a 36-day STIB247 T.b. brucei infection was estimated using phase 675 
microscopy and methodology outlined in 40. 676 
  677 
Supplementary Files 678 
 679 
Supplementary File 1. Histopathological assessment of inflammation in the skin during 680 
STIB247 infection 681 
The extent of cutaneous inflammatory cell infiltration during the 36-day STIB247 experiment was 682 
assessed on haematoxylin and eosin stained sections with a semi-quantitative scoring system 683 
applied by two pathologists blinded to group assignment and experimental procedures. The extent 684 
of mixed inflammatory cell infiltration in the dermis and/or subcutis was assessed on a 0 to 3 685 
grading scale (0 = no inflammation or only few scattered leukocytes; 1 = low numbers of 686 
inflammatory cells; 2 = moderate numbers of inflammatory cells; 3 = large numbers of inflammatory 687 
cells). Ten high-power fields (HPFs) were scored for each skin sample. 688 
 689 
Supplementary File 2. Histopathological assessment of inflammation in the skin during 690 
TREU927 infection 691 
The extent of cutaneous inflammatory cell infiltration at day 10 of infection by strain TREU927 692 
experiment was assessed on haematoxylin and eosin stained sections with a semi-quantitative 693 
scoring system applied by two pathologists blinded to group assignment and experimental 694 
procedures. The extent of mixed inflammatory cell infiltration in the dermis and/or subcutis was 695 
assessed on a 0 to 3 grading scale (0 = no inflammation or only few scattered leukocytes; 1 = low 696 
numbers of inflammatory cells; 2 = moderate numbers of inflammatory cells; 3 = large numbers of 697 
inflammatory cells). Ten high-power fields (HPFs) were scored for each skin sample. 698 
 699 
Supplementary File 3. Expression of PAD1 relative to ZFP3  700 
The relative abundance stumpy cells in the skin of three BALB/c was estimated using qPCR at day 701 
11 post-inoculation with T.b. brucei strain TREU927. Mice were culled and perfused to remove 702 
blood parasites and a 2cm2 region of skin removed from the flank. The tissue was homogenised and 703 
RNA extracted. 100ng of RNA from each sample was reverse-transcribed and qPCR performed to 704 
estimate the cycle thresholds (CT) of the stumpy marker PAD1 and the endogenous control ZFP3. 705 
As CT is inversely proportional to amount of target cDNA in the sample and PAD1 and ZFP3 have 706 
similar qPCR efficiencies, a comparison of the delta (∆) of CT between PAD1 and ZFP3 transcripts 707 
reveals the relative ratio of PAD1 to ZFP3 transcripts and hence the proportion of differentiated 708 
parasites transcribing the PAD1 gene. 709 
 710 
Supplementary File 4. Both the respective densities and the proportions of transmissible 711 
forms of parasites in the skin and in the blood govern the tsetse infection rates during pool 712 
feeding 713 
For some of the xenodiagnosis experiments shown in Table 1, identification and quantification of 714 
parasite stages was performed by IFA on blood smears and skin sections. Stumpy forms were 715 
observed only in the blood of mice with parasitaemia values highlighted in light grey. 716 
Bioluminescence was detected in the skin of mice with values highlighted in dark grey. The number 717 
of parasites in the skin was calculated according to the values obtained in the standard in vitro 718 
assay (Table 1-source data 1) and is therefore probably an underestimate. Tsetse flies were 719 
dissected 2 days after xenodiagnosis. Populations of intermediate and stumpy form cells were 720 
assessed in blood smears and in successive skin sections stained either with the anti-CRD antibody 721 
or the anti-PAD1 antibody (see Method section). Populations of early procyclic cells were assessed 722 
in dissected fly midguts stained with the anti-GPEET antibody (see Method section). ND: not 723 
determined. 724 
 725 
Video 1. Extravascular trypanosomes visualised in the skin using 2-photon microscopy 726 
Intravital multi-photon imaging of the flank skin during trypanosome infection 10 days after IP 727 
inoculation. An intravenous injection of non-targeted quantum dots prior to imaging allowed 728 
visualisation of blood vessels. mCherry STIB247 T.b. brucei parasites (red) are observed moving in 729 
the extravascular region surrounding blood vessels of the dermis (white). Collagen auto-730 
fluorescence is visible as green. 731 
 732 
Videos 2-4. Extravascular trypanosomes visualised in the skin using spinning-disk confocal 733 
microscopy 734 
Spinning-disk confocal live imaging of the ear of an Kdr (Flk1) C57BL/6J Rj mouse during a 735 
trypanosome infection after natural transmission. T.b. brucei AnTat1.1E AMLuc/tdTomato parasites 736 
expressing tdTomato (red) are observed moving in the extravascular region surrounding blood and / 737 
or lymphatic vessels of the dermis (green). 738 
 739 
 740 
 741 
 742 
